Household & Personal Products · Founded 1986 · www.galaxysurfactants.com · BSE 540935 · NSE GALAXYSURF · ISIN INE600K01018
No Notes Added Yet
Business
Galaxy Surfactants Ltd. is a leading manufacturer and supplier of performance surfactants and specialty care products. The company operates on a Business-to-Business (B2B) model, providing key ingredients to Fast Moving Consumer Goods (FMCG) companies for their personal care and home care products. These ingredients include surfactants, which are crucial for cleaning and foaming properties, and specialty ingredients that enhance product performance, stability, and sensory attributes. Galaxy's core business model involves R&D-driven product development, efficient manufacturing, and a global supply chain to serve a diverse client base, earning revenue through the sale of these chemical ingredients.
Revenue Mix
The company primarily operates in two product categories:
Performance Surfactants: These are the primary cleansing and foaming agents used in shampoos, body washes, detergents, and other personal/home care products.
Specialty Care Products: These include mild surfactants, blends, conditioning agents, preservatives, and various additives that offer specialized functionalities like skin conditioning, hair conditioning, or improved formulation stability.
Geographically, Galaxy Surfactants has a global presence, with significant revenue derived from exports to regions like the Americas, Europe, Africa, and other parts of Asia, alongside a strong domestic market presence in India. Precise revenue contribution by segment varies but both segments are crucial to its portfolio.
Industry
Galaxy Surfactants operates within the specialty chemicals industry, specifically catering to the personal and home care segments. This is a global, competitive, and innovation-driven industry characterized by a need for strong R&D, regulatory compliance, and reliable supply chains. The industry is seeing increasing demand for sustainable, mild, and natural ingredients. Galaxy Surfactants is positioned as a leading Indian manufacturer of surfactants and specialty care ingredients, recognized globally for its expertise in mild surfactants and a strong focus on green chemistry. It often acts as a preferred supplier to large multinational FMCG companies due to its technical capabilities and product quality.
MOAT
R&D and Innovation: Strong focus on developing new molecules, sustainable solutions, and customized products, particularly in mild and green chemistry, giving it an edge in catering to evolving consumer preferences.
Long-standing Customer Relationships & Switching Costs: Established relationships with large, global FMCG companies, where its specialized ingredients become integral to client formulations, creating high switching costs due to re-formulation, testing, and regulatory approval processes.
Technical Expertise & Regulatory Compliance: Deep technical knowledge allows for complex product development and adherence to stringent global regulatory standards, which is a barrier to entry for smaller players.
Manufacturing Scale & Integration: Efficient and integrated manufacturing facilities provide cost efficiencies and consistent quality, crucial for large-volume supplies.
Growth Drivers
Growing Personal & Home Care Markets: Increasing disposable incomes, urbanization, and hygiene awareness in emerging markets drive demand for personal care and home care products, subsequently increasing the need for ingredients.
Shift Towards Sustainable & Mild Chemistry: Rising consumer preference and regulatory push for mild, natural, and environmentally friendly ingredients create opportunities for Galaxy's R&D-led portfolio.
New Product Development & Customization: Continuous innovation and ability to offer tailored solutions to clients help capture new market share and cater to evolving product trends.
Global Expansion: Further penetration into untapped or under-served international markets provides avenues for volume and revenue growth.
Risks
Raw Material Price Volatility: The company is exposed to fluctuations in prices of key raw materials, often crude oil and palm oil derivatives, which can impact profit margins.
Intense Competition: The specialty chemicals market is competitive, with both global and regional players, potentially leading to pricing pressures or loss of market share.
Foreign Exchange Fluctuations: Significant international revenues and expenditures expose the company to currency risks.
Regulatory Changes: Evolving environmental and chemical safety regulations globally could necessitate costly changes in manufacturing processes or product formulations.
Customer Concentration: While diverse, reliance on a few large FMCG clients for a substantial portion of revenue can pose a risk if one key client shifts sourcing.
Management & Ownership
Galaxy Surfactants is a promoter-led company with a professional management team. It was founded by Mr. Shekhar Satyanarayan. The promoter group, including Mr. Satyanarayan, holds a significant stake in the company, aligning their interests with long-term shareholder value creation. The management team is generally perceived as technically strong with a focus on R&D and operational excellence within the specialty chemicals sector. The ownership structure includes a substantial promoter holding alongside institutional investors and public shareholders.
Outlook
Galaxy Surfactants is well-positioned to capitalize on the sustained growth of the global personal and home care markets, particularly given the increasing consumer demand for mild, sustainable, and high-performance ingredients. Its strong R&D capabilities, long-standing client relationships, and focus on green chemistry provide a robust foundation for future growth. However, the company remains exposed to external factors such as volatile raw material prices, intense competition in the global specialty chemicals market, and foreign exchange fluctuations, which could impact profitability. While its strategic focus on innovation and sustainability offers a competitive edge, navigating these macro and industry-specific challenges will be crucial for maintaining its growth trajectory and profitability.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 929 | 974 | 1063 | 1042 | 1145 | 1278 | 1326 | 1329 | 1315 | 1782 |
| Other Income | 24 | 5 | 9 | 4 | 8 | 11 | 6 | 5 | 0 | 3 |
| Total Income | 953 | 979 | 1072 | 1046 | 1153 | 1289 | 1332 | 1334 | 1315 | 1785 |
| Total Expenditure | 827 | 850 | 935 | 936 | 1018 | 1154 | 1216 | 1210 | 1193 | 1533 |
| Operating Profit | 126 | 129 | 136 | 110 | 135 | 135 | 116 | 124 | 122 | 252 |
| Interest | 5 | 4 | 4 | 5 | 6 | 7 | 7 | 9 | 8 | 9 |
| Depreciation | 26 | 27 | 28 | 28 | 28 | 29 | 30 | 31 | 33 | 36 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -12 | 0 | 0 |
| Profit Before Tax | 94 | 99 | 104 | 77 | 100 | 99 | 79 | 73 | 80 | 207 |
| Provision for Tax | 16 | 19 | 20 | 12 | 24 | 20 | 13 | 14 | 18 | 41 |
| Profit After Tax | 78 | 80 | 85 | 65 | 76 | 79 | 66 | 59 | 62 | 166 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 78 | 80 | 85 | 65 | 76 | 79 | 66 | 59 | 62 | 166 |
| Adjusted Earnings Per Share | 21.9 | 22.5 | 23.9 | 18.2 | 21.4 | 22.4 | 18.8 | 16.6 | 17.6 | 46.8 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 1801 | 2161 | 2434 | 2763 | 2596 | 2784 | 3686 | 4464 | 3794 | 4224 | 5248 | 5752 |
| Other Income | 6 | 10 | 10 | 11 | 7 | 12 | 14 | 11 | 37 | 27 | 32 | 14 |
| Total Income | 1807 | 2172 | 2444 | 2774 | 2604 | 2796 | 3699 | 4475 | 3831 | 4251 | 5280 | 5766 |
| Total Expenditure | 1568 | 1890 | 2146 | 2416 | 2229 | 2337 | 3286 | 3897 | 3334 | 3741 | 4783 | 5152 |
| Operating Profit | 240 | 282 | 298 | 358 | 375 | 460 | 413 | 578 | 498 | 510 | 497 | 614 |
| Interest | 33 | 27 | 31 | 30 | 24 | 13 | 13 | 22 | 22 | 19 | 31 | 33 |
| Depreciation | 45 | 47 | 49 | 51 | 62 | 74 | 71 | 83 | 100 | 110 | 123 | 130 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -12 | -12 |
| Profit Before Tax | 161 | 207 | 219 | 277 | 289 | 372 | 329 | 473 | 375 | 380 | 332 | 439 |
| Provision for Tax | 60 | 60 | 61 | 86 | 58 | 70 | 67 | 92 | 74 | 76 | 64 | 86 |
| Profit After Tax | 101 | 148 | 158 | 191 | 230 | 302 | 263 | 381 | 301 | 305 | 267 | 353 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 101 | 148 | 158 | 191 | 230 | 302 | 263 | 381 | 301 | 305 | 267 | 353 |
| Adjusted Earnings Per Share | 28.5 | 41.6 | 44.6 | 53.9 | 65 | 85.2 | 74.1 | 107.5 | 85 | 86 | 75.4 | 99.8 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 24% | 6% | 14% | 11% |
| Operating Profit CAGR | -3% | -5% | 2% | 8% |
| PAT CAGR | -12% | -11% | -2% | 10% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 7% | -3% | -7% | NA% |
| ROE Average | 10% | 13% | 16% | 21% |
| ROCE Average | 13% | 16% | 18% | 22% |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 442 | 575 | 719 | 877 | 1068 | 1301 | 1574 | 1883 | 2179 | 2363 | 2745 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 194 | 128 | 72 | 89 | 117 | 77 | 80 | 89 | 46 | 17 | 6 |
| Other Non-Current Liabilities | 29 | 30 | 32 | 38 | 58 | 50 | 77 | 76 | 78 | 92 | 98 |
| Total Current Liabilities | 435 | 549 | 629 | 559 | 569 | 620 | 865 | 680 | 603 | 978 | 1016 |
| Total Liabilities | 1100 | 1283 | 1452 | 1563 | 1812 | 2049 | 2597 | 2728 | 2906 | 3450 | 3865 |
| Fixed Assets | 436 | 456 | 447 | 519 | 748 | 712 | 760 | 923 | 973 | 1030 | 1174 |
| Other Non-Current Assets | 81 | 71 | 86 | 147 | 129 | 179 | 266 | 202 | 231 | 326 | 249 |
| Total Current Assets | 584 | 756 | 919 | 897 | 935 | 1158 | 1570 | 1602 | 1702 | 2094 | 2443 |
| Total Assets | 1100 | 1283 | 1452 | 1563 | 1812 | 2049 | 2597 | 2728 | 2906 | 3450 | 3865 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 14 | 15 | 26 | 27 | 25 | 48 | 82 | 64 | 232 | 220 | 193 |
| Cash Flow from Operating Activities | 170 | 111 | 145 | 283 | 316 | 365 | 5 | 573 | 518 | 421 | 333 |
| Cash Flow from Investing Activities | -59 | -43 | -55 | -167 | -151 | -165 | -84 | -149 | -344 | -295 | -378 |
| Cash Flow from Financing Activities | -110 | -57 | -90 | -119 | -144 | -165 | 59 | -264 | -189 | -157 | -51 |
| Net Cash Inflow / Outflow | 0 | 11 | 1 | -4 | 21 | 35 | -20 | 160 | -14 | -31 | -96 |
| Closing Cash & Cash Equivalent | 14 | 26 | 27 | 25 | 48 | 82 | 64 | 232 | 220 | 193 | 109 |
| # | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 28.53 | 41.64 | 44.58 | 53.87 | 65 | 85.23 | 74.13 | 107.47 | 85.04 | 86.01 | 75.42 |
| CEPS(Rs) | 41.28 | 54.94 | 58.27 | 68.32 | 82.54 | 106.09 | 94.17 | 131.02 | 113.2 | 117.14 | 110.12 |
| DPS(Rs) | 6 | 6 | 7 | 8 | 14 | 18 | 18 | 22 | 22 | 22 | 22 |
| Book NAV/Share(Rs) | 124.6 | 162.17 | 202.76 | 247.31 | 301.2 | 367.11 | 444.1 | 531.04 | 614.74 | 666.44 | 773.62 |
| Core EBITDA Margin(%) | 12.49 | 12.07 | 11.68 | 12.57 | 14.15 | 16.07 | 10.84 | 12.71 | 12.14 | 11.43 | 8.87 |
| EBIT Margin(%) | 10.38 | 10.44 | 10.12 | 11.11 | 12.04 | 13.86 | 9.28 | 11.08 | 10.49 | 9.46 | 6.91 |
| Pre Tax Margin(%) | 8.63 | 9.23 | 8.88 | 10.02 | 11.12 | 13.37 | 8.93 | 10.59 | 9.9 | 9.01 | 6.32 |
| PAT Margin (%) | 5.41 | 6.57 | 6.42 | 6.91 | 8.87 | 10.85 | 7.13 | 8.53 | 7.95 | 7.22 | 5.09 |
| Cash Profit Margin (%) | 7.82 | 8.66 | 8.39 | 8.77 | 11.27 | 13.51 | 9.06 | 10.4 | 10.58 | 9.83 | 7.44 |
| ROA(%) | 9.38 | 12.39 | 11.56 | 12.67 | 13.65 | 15.65 | 11.31 | 14.31 | 10.7 | 9.59 | 7.31 |
| ROE(%) | 25.21 | 29.04 | 24.43 | 23.94 | 23.7 | 25.51 | 18.28 | 22.04 | 14.84 | 13.43 | 10.48 |
| ROCE(%) | 23.36 | 25.79 | 24.51 | 27.38 | 23.92 | 25.63 | 19.5 | 24.16 | 17.82 | 16.6 | 13.39 |
| Receivable days | 45.99 | 48.5 | 56.73 | 55.81 | 60.88 | 59.54 | 54.81 | 51.22 | 58.1 | 55.29 | 49.96 |
| Inventory Days | 46.99 | 44.91 | 49.14 | 46.03 | 47.54 | 49.35 | 56.43 | 55.5 | 57.81 | 55.3 | 52.77 |
| Payable days | 57.52 | 54.73 | 62.79 | 61.3 | 63.73 | 69.32 | 65.08 | 57.48 | 64.33 | 69.59 | 60.46 |
| PER(x) | 0 | 0 | 33.65 | 19.84 | 18.04 | 29.98 | 38.66 | 21.71 | 26.69 | 23.85 | 20.08 |
| Price/Book(x) | 0 | 0 | 7.4 | 4.32 | 3.89 | 6.96 | 6.45 | 4.39 | 3.69 | 3.08 | 1.96 |
| Dividend Yield(%) | 0 | 0 | 0.47 | 0.75 | 1.19 | 0.7 | 0.63 | 0.94 | 0.97 | 1.07 | 1.45 |
| EV/Net Sales(x) | 0.24 | 0.19 | 2.32 | 1.47 | 1.72 | 3.31 | 2.84 | 1.86 | 2.09 | 1.7 | 1 |
| EV/Core EBITDA(x) | 1.79 | 1.43 | 18.93 | 11.34 | 11.94 | 20.05 | 25.3 | 14.35 | 15.95 | 14.11 | 10.57 |
| Net Sales Growth(%) | -3.76 | 19.98 | 12.61 | 13.52 | -6.03 | 7.23 | 32.39 | 21.12 | -15 | 11.31 | 24.26 |
| EBIT Growth(%) | 30.19 | 20.77 | 6.26 | 23.07 | 1.89 | 23.38 | -11.3 | 44.57 | -19.57 | 0.46 | -9.31 |
| PAT Growth(%) | 48.74 | 45.97 | 7.05 | 20.85 | 20.65 | 31.13 | -13.03 | 44.98 | -20.87 | 1.14 | -12.31 |
| EPS Growth(%) | 48.74 | 45.97 | 7.05 | 20.85 | 20.65 | 31.13 | -13.03 | 44.98 | -20.87 | 1.14 | -12.31 |
| Debt/Equity(x) | 0.93 | 0.68 | 0.48 | 0.34 | 0.35 | 0.21 | 0.23 | 0.14 | 0.06 | 0.06 | 0.06 |
| Current Ratio(x) | 1.34 | 1.38 | 1.46 | 1.61 | 1.64 | 1.87 | 1.81 | 2.36 | 2.82 | 2.14 | 2.4 |
| Quick Ratio(x) | 0.8 | 0.8 | 0.91 | 0.98 | 1.07 | 1.18 | 0.99 | 1.41 | 1.9 | 1.4 | 1.62 |
| Interest Cover(x) | 5.92 | 8.62 | 8.16 | 10.23 | 13.14 | 28.74 | 26.63 | 22.79 | 17.76 | 20.76 | 11.75 |
| Total Debt/Mcap(x) | 0 | 0 | 0.07 | 0.08 | 0.09 | 0.03 | 0.04 | 0.03 | 0.02 | 0.02 | 0.03 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 70.91 | 70.91 | 70.91 | 70.91 | 70.91 | 70.91 | 70.91 | 70.91 | 70.9 | 70.9 |
| FII | 3.76 | 3.87 | 4.08 | 4.19 | 4.09 | 4.29 | 4.22 | 4.09 | 3.99 | 3.82 |
| DII | 12.73 | 12.71 | 12.99 | 12.98 | 12.95 | 12.7 | 12.9 | 13.05 | 13.1 | 13.52 |
| Public | 12.6 | 12.5 | 12.02 | 11.92 | 12.05 | 12.09 | 11.97 | 11.96 | 12.01 | 11.76 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 2.51 | 2.51 | 2.51 | 2.51 | 2.51 | 2.51 | 2.51 | 2.51 | 2.51 | 2.51 |
| FII | 0.13 | 0.14 | 0.14 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.14 | 0.14 |
| DII | 0.45 | 0.45 | 0.46 | 0.46 | 0.46 | 0.45 | 0.46 | 0.46 | 0.46 | 0.48 |
| Public | 0.45 | 0.44 | 0.43 | 0.42 | 0.43 | 0.43 | 0.42 | 0.42 | 0.43 | 0.42 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3.55 | 3.55 | 3.55 | 3.55 | 3.55 | 3.55 | 3.55 | 3.55 | 3.55 | 3.55 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +24% | +6% | +14% | +11% |
| Operating Profit CAGR | -3% | -5% | +2% | +8% |
| PAT CAGR | -12% | -11% | -2% | +10% |
| Share Price CAGR | +7% | -3% | -7% | — |
| ROE Average | +10% | +13% | +16% | +21% |
| ROCE Average | +13% | +16% | +18% | +22% |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 70.91 | 70.91 | 70.91 | 70.91 | 70.91 | 70.91 | 70.91 | 70.91 | 70.9 | 70.9 |
| FII | 3.76 | 3.87 | 4.08 | 4.19 | 4.09 | 4.29 | 4.22 | 4.09 | 3.99 | 3.82 |
| DII | 12.73 | 12.71 | 12.99 | 12.98 | 12.95 | 12.7 | 12.9 | 13.05 | 13.1 | 13.52 |
| Public | 12.6 | 12.5 | 12.02 | 11.92 | 12.05 | 12.09 | 11.97 | 11.96 | 12.01 | 11.76 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 2.51 | 2.51 | 2.51 | 2.51 | 2.51 | 2.51 | 2.51 | 2.51 | 2.51 | 2.51 |
| FII | 0.13 | 0.14 | 0.14 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.14 | 0.14 |
| DII | 0.45 | 0.45 | 0.46 | 0.46 | 0.46 | 0.45 | 0.46 | 0.46 | 0.46 | 0.48 |
| Public | 0.45 | 0.44 | 0.43 | 0.42 | 0.43 | 0.43 | 0.42 | 0.42 | 0.43 | 0.42 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3.55 | 3.55 | 3.55 | 3.55 | 3.55 | 3.55 | 3.55 | 3.55 | 3.55 | 3.55 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.